Erica Lazarus

Also affiliated with Perinatal HIV Research Unit

Immunology and MicrobiologyMedicineHealth Professions

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition”.

Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition

New England Journal of Medicine(2021)10.1056/nejmoa2031738

N/A

6.2DataRank · unranked

547 citations

Peter B. Gilbert, Michal Juraska, David C. Montefiori, Lynn Morris, Shelly Karuna +40 more

Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study

The Lancet(2022)10.1016/s0140-6736(22)00007-1

N/A

4.4DataRank · unranked

85 citations

Nigel Garrett, Ameena Goga, Lara Fairall, Tarylee Reddy, Nonhlanhla Yende-Zuma +76 more

Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial

The Lancet Infectious Diseases(2024)10.1016/s1473-3099(24)00358-x

N/A

1.3DataRank · unranked

40 citations

Kathryn Mngadi, Ludo Lavreys, Steven Nijs, Peter B. Gilbert, John Hural +60 more

Analysis of the HIV Vaccine Trials Network 702 Phase 2b–3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk

The Journal of Infectious Diseases(2022)10.1093/infdis/jiac260

N/A

1.1DataRank · unranked

50 citations

One Dintwe, Sheetal Sawant, Doug Grove, Yunda Huang, Holly Janes +43 more

A Phase 2b Study to Evaluate the Safety and Efficacy of VRC01 Broadly Neutralizing Monoclonal Antibody in Reducing Acquisition of HIV-1 Infection in Women in Sub-Saharan Africa: Baseline Findings

UNC Libraries(2023)10.17615/42e2-fv64

N/A

0DataRank · unranked

0 citations

Simbarashe Takuva, Nyaradzo Mgodi, Srilatha Edupuganti, Gomez Lorenzo, M.M., Maurine D. Miner +24 more

Pharmacokinetics and predicted neutralisation coverage of VRC01 in HIV-uninfected participants of the Antibody Mediated Prevention (AMP) trials

UNC Libraries(2023)10.17615/f8gd-ra57

N/A

0DataRank · unranked

0 citations

Paula González, Kathryn Mngadi, John R. Mascola, L. Naidoo, Peter B. Gilbert +18 more

Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study

EBioMedicine(2024)10.1016/j.ebiom.2024.105320

N/A

0DataRank · unranked

16 citations

Janine van Duijn, One Dintwe, Jack Heptinstall, Randy I. Burnham, Sheetal Sawant +93 more

A mixed methods investigation of implementation barriers and facilitators to a daily mobile phone sexual risk assessment for young women in Soweto, South Africa

PLoS ONE(2020)10.1371/journal.pone.0231086

N/A

0DataRank · unranked

17 citations

Stefanie Hornschuh, Mamakiri Khunwane, Lerato M. Makhale, Kennedy Otwombe, Cecilia Morgan +9 more

Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants

PLOS Global Public Health(2024)10.1371/journal.pgph.0002703

N/A

0DataRank · unranked

12 citations

Jinal N. Bhiman, Yashica Ganga, Shobna Sawry, Frances Ayres, Richard Baguma +51 more

Pharmacokinetics and predicted neutralisation coverage of VRC01 in HIV-uninfected participants of the Antibody Mediated Prevention (AMP) trials

EBioMedicine(2021)10.1016/j.ebiom.2020.103203

N/A

0DataRank · unranked

29 citations

Logashvari Naidoo, Lily Zhang, Lindsay N. Carpp, Erika Rudnicki, April K. Randhawa +18 more

High Asymptomatic Carriage With the Omicron Variant in South Africa

Clinical Infectious Diseases(2022)10.1093/cid/ciac237

N/A

0DataRank · unranked

81 citations

Asa Tapley, Jessica Andriesen, Ishen Seocharan, Leigh H. Fisher, Lisa Bunts +85 more

Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants

medRxiv(2023)10.1101/2023.11.20.23298785

N/A

0DataRank · unranked

5 citations

Jinal N. Bhiman, Yashica Ganga, Shobna Sawry, Frances Ayres, Richard Baguma +51 more